-
Founded in:
2000-12-28 -
Country:
China -
Address:
Lingqian Town, Sanyuan County, Xianyang City, Shaanxi Province -
Tax NO.:
91610000719707197J -
Registered Funds:
50 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Valsartan |
Valsartan is an orally effective specific angiotensin (AT) II receptor antagonist that selectively acts on the AT1 receptor subtype and does not affect the AT2 receptor subtype. It lowers blood pressure by blocking the physiological effects of angiotensin II, does not affect heart rate, does not inhibit ACE enzyme, and is not likely to cause cough. Combined use with hydrochlorothiazide significantly enhances the antihypertensive effect.
More
Valsartan is an orally effective specific angiotensin (AT) II receptor antagonist that selectively acts on the AT1 receptor subtype and does not affect the AT2 receptor subtype. It lowers blood pressure by blocking the physiological effects of angiotensin II, does not affect heart rate, does not inhibit ACE enzyme, and is not likely to cause cough. Combined use with hydrochlorothiazide significantly enhances the antihypertensive effect. |
80mg | 137862-53-4 | 80 |
| Hydrochlorothiazide |
Hydrochlorothiazide is a thiazide diuretic that mainly acts on the proximal end of the distal convoluted tubule, inhibiting the co-transport of sodium and chloride ions, increasing the excretion of sodium and chloride, indirectly reducing plasma volume, increasing plasma renin activity and aldosterone secretion, and leading to potassium loss. Combination use with valsartan can reduce potassium loss.
More
Hydrochlorothiazide is a thiazide diuretic that mainly acts on the proximal end of the distal convoluted tubule, inhibiting the co-transport of sodium and chloride ions, increasing the excretion of sodium and chloride, indirectly reducing plasma volume, increasing plasma renin activity and aldosterone secretion, and leading to potassium loss. Combination use with valsartan can reduce potassium loss. |
12.5mg | 58-93-5 | 56 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| NOTOGINSENG RADIX ET RHIZOMA |
|
0 | ||
| Paeoniae Rubra |
|
0 | ||
| Citri Sarcodactylis Fructus |
|
0 | ||
| ALISMATIS RHIZOMA |
|
0 | ||
| DGL |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Radix astragali preparata |
|
0 | ||
| POLYGONI MULTIFLORI RADIX PRAEPARATA |
|
0 | ||
| donkey-hide gelatin |
|
0 | ||
| REHMANNIAE RADIX PRAEPARATA |
|
0 | ||
| ASIAN GINSENG |
|
0 | ||
| Citri reticulatae pericarpium |
|
0 | ||
| Aucklandiae Radix |
|
0 | ||
| DGL |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Bendazol |
|
621-72-7 | 1 | |
| Promethazine hydrochloride |
|
58-33-3 | 29 | |
| Chloroquine diphosphate |
|
50-63-5 | 11 | |
| GUANOXAN SULFATE |
|
5714-04-5 | 1 | |
| Vitamin B6 |
|
8059-24-3 | 13 | |
| Potassium chloride |
|
7447-40-7 | 38 | |
| Reserpine |
|
50-55-5 | 19 | |
| Chlordiazepoxide |
|
0 | ||
| Hydrochlorothiazide |
|
58-93-5 | 56 | |
| Calcium lactate |
|
814-80-2 | 10 | |
| Thiamine chloride |
|
59-43-8 | 9 | |
| Magnesium trisilicate |
|
14987-04-3 | 11 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Diclofenac potassium |
This product is a non-steroidal anti-inflammatory drug with a fast onset of action. It may produce analgesic, anti-inflammatory and antipyretic effects mainly by inhibiting the synthesis of prostaglandins. This product has no accumulation effect.
More
This product is a non-steroidal anti-inflammatory drug with a fast onset of action. It may produce analgesic, anti-inflammatory and antipyretic effects mainly by inhibiting the synthesis of prostaglandins. This product has no accumulation effect. |
15307-81-0 | 24 |